References
- Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-57. https://doi.org/10.1378/chest.122.3.1037
- Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694-705. https://doi.org/10.1097/JTO.0b013e31812d05d5
- Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13-21. https://doi.org/10.1016/0092-8674(94)90396-4
- Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009;458:438-44. https://doi.org/10.1038/nature07960
- Su V, Lau AF. Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation. Cell Mol Life Sci 2009;66:2819-33. https://doi.org/10.1007/s00018-009-0048-9
- White RE, Powell DJ, Berry C. HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites. FASEB J 2011;25:1729-36. https://doi.org/10.1096/fj.10-178947
- Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, et al. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 2007; 13:5183-94. https://doi.org/10.1158/1078-0432.CCR-07-0161
- Gills JJ, Lopiccolo J, Dennis PA. Nelfinavir, a new anti- cancer drug with pleiotropic effects and many paths to autophagy. Autophagy 2008;4:107-9. https://doi.org/10.4161/auto.5224
- Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007;110:1532-41. https://doi.org/10.1002/cncr.22938
- Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P, et al. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009;4:792-801. https://doi.org/10.1097/JTO.0b013e3181a7716e
- Kaplun L, Tzirkin R, Bakhrat A, Shabek N, Ivantsiv Y, Raveh D. The DNA damage-inducible UbL-UbA protein Ddi1 participates in Mec1-mediated degradation of Ho endonuclease. Mol Cell Biol 2005;25:5355-62. https://doi.org/10.1128/MCB.25.13.5355-5362.2005
- Wilkinson CR, Wallace M, Morphew M, Perry P, Allshire R, Javerzat JP, et al. Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J 1998;17:6465-76. https://doi.org/10.1093/emboj/17.22.6465
- Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, et al. Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA 1990;87:7071-5. https://doi.org/10.1073/pnas.87.18.7071
- Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, et al. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res 1991;51:6677-85.
- Goldknopf IL, Wilson G, Ballal NR, Busch H. Chromatin conjugate protein A24 is cleaved and ubiquitin is lost during chicken erythropoiesis. J Biol Chem 1980;255: 10555-8.
- Agell N, Mezquita C. Cellular content of ubiquitin and formation of ubiquitin conjugates during chicken spermatogenesis. Biochem J 1988;250:883-9. https://doi.org/10.1042/bj2500883
- Ishibashi Y, Takada K, Joh K, Ohkawa K, Aoki T, Matsuda M. Ubiquitin immunoreactivity in human malignant tumours. Br J Cancer 1991;63:320-2. https://doi.org/10.1038/bjc.1991.75